HoldsUp

The Diary Of A CEO · 2026-02-09 · Steven Bartlett (host), Michael Breus

Sleep Doctor: If You Wake Up At 3AM, DO NOT Do This!

85 research-tied claims examined: 14 contradicted 10 overstated 10 context 33 supported 18 unverified

10

Needs context

0:26:53Michael Breusneeds contexthigh

The elimination half-life of caffeine is between 6 and 8 hours.

"the half-life of caffeine is between 6 and 8 hours." (said at 0:26:53)

Pharmacokinetic studies in healthy adults indicate that the mean elimination half-life of caffeine typically ranges between 3 and 7 hours (most commonly averaging around 4 to 6 hours), rather than a narrow window of 6 to 8 hours. However, caffeine clearance exhibits substantial inter-individual variability: smoking accelerates clearance (shortening half-life), whereas oral contraceptive use, pregnancy, and certain genetic variations significantly prolong half-life (often exceeding 6 to 10 hours).

0:42:36Michael Breusneeds contexthigh

Alpha brainwaves correspond to the brain's most relaxed state when eyes are closed.

"the alpha state is when your eyes are closed and you're at the most relaxed state of your brainwaves. It's called the alpha state." (said at 0:42:36)

In electrophysiology, prominent alpha oscillations (8–13 Hz), particularly over the occipital cortex, are the classic marker of relaxed, resting wakefulness when the eyes are closed. However, calling alpha the "most relaxed state" requires qualification: alpha reflects relaxed baseline wakefulness, whereas deeper states of physiological deactivation, drowsiness, deep meditation, and sleep transition into slower oscillatory regimes, namely theta (4–8 Hz) and delta (0.5–4 Hz) waves.

0:45:48Michael Breusneeds contextlow

Approximately 75% of people sleep on their sides.

"75% of people sleep on their sides and they kind of squanch up, which means they're putting pressure on their bladder." (said at 0:45:48)

Epidemiological and observational sleep posture studies show that adults spend a majority of their sleep time in lateral (side) sleeping positions, and preference for side sleeping increases significantly with age (becoming the dominant position in older adults). For example, objective polysomnographic and video monitoring of sleep positions across age groups found that while young children divide sleep time roughly equally among prone, supine, and lateral positions, adults progressively spend the majority of their sleep time in side-sleeping positions (PMID: 1579788). However, claims of a single fixed percentage like 75% for all adults simplify varying observational estimates, and there is no physiological evidence that typical side sleeping creates harmful pressure on the bladder.

0:46:08Michael Breusneeds contextmoderate

Turning on bathroom lights in the middle of the night signals morning to the brain and halts melatonin production.

"If you're going to go to the bathroom, have a strategically placed nightlight along the way so you don't have to flip on the light in the water closet cuz if you do that, you just told your brain it's morning and it stops producing melatonin." (said at 0:46:08)

The speaker claims that turning on an overhead bathroom light in the middle of the night signals morning to the brain and stops melatonin production. While exposure to light during the night suppresses melatonin secretion in a dose- and spectrum-dependent manner, the claim overstates the duration and nature of this effect for a brief bathroom visit. Research shows that bright light exposure during the night acutely suppresses salivary and serum melatonin levels (PMID: 14564894, PMID: 2056432, PMID: 38123771). For instance, a 15-minute pulse of bright light significantly suppresses serum melatonin (PMID: 2056432), and a 60-minute pulse of light suppresses salivary melatonin (PMID: 14564894). However, studies demonstrate that this suppression is transient and typically reverses after the light exposure ends (PMID: 14564894, PMID: 2056432). Furthermore, brief exposure does not permanently halt melatonin production or instantly lock the brain into a daytime circadian state, though it can induce circadian phase shifts depending on timing, intensity, and individual sensitivity (PMID: 36508661, PMID: 38534797). Thus, while using low-level nightlights reduces nocturnal melatonin suppression, overhead lighting causes temporary suppression rather than a complete or permanent shutdown of nighttime melatonin production.

1:12:43Steven Bartlett (host)needs contextlow

Research from the Queensland Brain Institute at the University of Queensland found that individuals with untreated sleep apnea have a 45% higher risk of developing Alzheimer's disease.

"The Queensland Brain Institute, at the University of Queensland, found that people with untreated apnea have a 45% higher risk of developing Alzheimer's disease." (said at 1:12:43)

The landmark sleep apnea and Alzheimer's disease study from the Queensland Brain Institute at the University of Queensland was an experimental animal study in mice, not a human epidemiological study establishing a 45% risk increase. The QBI study demonstrated that sleep-disordered breathing and resulting hypoxia caused selective cholinergic basal forebrain degeneration and exacerbated Alzheimer's pathology in mice, and that preventing hypoxia averted these changes. Broader human epidemiological meta-analyses do confirm that sleep apnea is associated with a significantly increased risk of Alzheimer's disease and dementia (pooled hazard ratios typically ranging from 1.28 to 1.52), but attributing a specific 45% human risk calculation directly to research conducted at the Queensland Brain Institute conflates general epidemiological findings with their mechanistic mouse model.

1:16:00Michael Breusneeds contexthigh

Sunlight hitting melanopsin-containing retinal ganglion cells in the morning turns off melatonin production and sets an internal biological timer for melatonin release approximately 14 hours later.

"When you wake up in the morning, sunlight hits your eye and you have a special cell in your eye called a melanopsin cell, which sends a signal to your brain to turn off the melatonin faucet in your head. But it sets a timer for exactly 14 hours later. It's called the melatonin phase response curve." (said at 1:16:00)

The biological mechanism described is largely accurate in concept but simplified. Melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) detect ambient light and transmit signals directly to the suprachiasmatic nucleus (SCN) of the hypothalamus, which suppresses pineal melatonin secretion and synchronizes circadian rhythms. In regular entrained sleep-wake schedules, dim light melatonin onset (DLMO) typically begins approximately 14 hours after morning awakening. However, this is not an exact mechanical countdown timer. Instead, circadian timing is governed by an endogenous ~24-hour oscillator. Furthermore, the 'phase response curve' (PRC) describes how the direction and magnitude of circadian phase shifts (phase advances or phase delays) vary depending on the circadian phase at which a stimulus (such as light or exogenous melatonin) occurs, rather than acting as a fixed 14-hour timer.

1:22:46Michael Breusneeds contextmoderate

Most children naturally produce approximately four times the amount of melatonin their brains require.

"most children make almost four times the amount of melatonin that their brain even needs. So giving them extra melatonin doesn't do you any good." (said at 1:22:46)

The claim conflates physiological differences between age groups with baseline biological requirements. Endocrine research established that young children (ages 1–5) exhibit nocturnal serum melatonin concentrations roughly four- to five-fold higher than young adults (~210 pg/mL vs. ~46 pg/mL), primarily because pineal melatonin output occurs into a much smaller body and plasma volume before puberty. However, this physiological ~4-fold elevation relative to adult levels does not mean that children produce four times the amount of melatonin their brains require or that the physiological levels represent an unneeded surplus.

1:25:36Michael Breusneeds contextmoderate

Endogenous melatonin production in the human body begins to decline around age 50.

"right around age 50 is when if you're going to have a melatonin deficiency, we start to see that happening for people, is that their ability to produce melatonin begins to decline." (said at 1:25:36)

While lower nocturnal melatonin secretion is observed in older adults and postmenopausal women, endogenous melatonin production does not *begin* to decline at age 50. Studies demonstrate that peak melatonin production occurs in early childhood, after which levels decline progressively through puberty and adulthood. Furthermore, controlled studies in strictly healthy, drug-free older individuals show that a decline in circadian melatonin amplitude is not a universal feature of healthy aging.

1:16:00Michael Breusneeds contextmoderate

Melatonin is an effective clinical treatment for REM sleep behavior disorder.

"and then also for a very specific sleeping disorder called REM behavior disorder." (said at 1:16:00)

Melatonin is widely used and recommended as a first-line clinical treatment for rapid eye movement (REM) sleep behavior disorder (RBD) alongside clonazepam, particularly due to its favorable safety profile. Meta-analyses and observational studies show improvements in polysomnographic parameters such as sleep efficiency, phasic activity, and tonic REM muscle activity. However, high-quality double-blind randomized placebo-controlled trials (RCTs) show mixed and inconsistent clinical efficacy; for example, a randomized controlled trial in Parkinson's disease patients with RBD found no significant difference between melatonin and placebo in reducing weekly RBD events.

1:43:56Michael Breusneeds contextlow

Vitamin D helps regulate melatonin production in the body.

"Vitamin D does a whole host of important things to your body, but most importantly from a sleep perspective is it helps regulate melatonin and when your body produces it." (said at 1:43:56)

Mechanistic and preclinical research shows that vitamin D is involved in the pathway of melatonin production by regulating the transcription of tryptophan hydroxylase (TPH2), the rate-limiting enzyme in serotonin synthesis (which is the direct precursor to melatonin). Vitamin D receptors are also expressed in brain areas that regulate sleep-wake cycles. However, evidence connecting vitamin D directly to the regulation of melatonin secretion and timing in humans is primarily derived from molecular pathways and narrative reviews rather than robust interventional clinical trials.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.